Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,245 | 102,014 | 89,356 | 54,771 | 113,326 |
| Marketable Securities | 453,992 | 513,473 | 644,817 | 708,831 | 534,575 |
| Receivables | 79,801 | 77,609 | 65,814 | 85,058 | 60,047 |
| Inventories | 12,953 | 13,611 | 12,528 | 14,789 | 30,940 |
| TOTAL | $702,069 | $742,678 | $854,848 | $903,544 | $776,602 |
| Non-Current Assets | |||||
| PPE Net | 36,050 | 36,593 | 37,850 | 40,167 | 41,947 |
| Investments And Advances | 323,547 | 277,149 | 176,879 | 132,658 | 115,492 |
| Other Non-Current Assets | 133,938 | 123,393 | 130,072 | 127,191 | 104,434 |
| TOTAL | $493,535 | $437,135 | $344,801 | $300,016 | $261,873 |
| Total Assets | $1,195,604 | $1,179,813 | $1,199,649 | $1,203,560 | $1,038,475 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 43,797 | 43,917 | 45,032 | 48,259 | 30,180 |
| Accounts payable and accrued liabilities | 800 | 6,790 | 4,716 | 4,858 | 4,926 |
| Accrued Expenses | 122,055 | 133,088 | 130,881 | 120,539 | 107,277 |
| Other current liabilities | 67,917 | 61,650 | 59,903 | 53,741 | 44,729 |
| TOTAL | $250,584 | $260,796 | $257,661 | $243,803 | $206,603 |
| Non-Current Liabilities | |||||
| Long Term Debt | 343,949 | 343,053 | 341,537 | 338,655 | 209,205 |
| Deferred Revenues | 2,279 | 2,005 | 4,118 | 3,748 | 7,251 |
| Other Non-Current Liabilities | 250,903 | 269,106 | 279,387 | 292,820 | 307,345 |
| TOTAL | $602,889 | $620,352 | $628,840 | $639,516 | $521,185 |
| Total Liabilities | $853,473 | $881,148 | $886,501 | $883,319 | $727,788 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,582 | 63,906 | 63,526 | 63,345 | 62,617 |
| Common Shares | 65 | 64 | 63 | 63 | 63 |
| Retained earnings | -2,406,535 | -2,407,031 | -2,357,076 | -2,300,800 | -2,250,806 |
| Other shareholders' equity | -3,237 | -3,551 | -1,070 | -3,890 | -3,847 |
| TOTAL | $342,131 | $298,665 | $313,148 | $320,241 | $310,687 |
| Total Liabilities And Equity | $1,195,604 | $1,179,813 | $1,199,649 | $1,203,560 | $1,038,475 |